BioSpace News Archive

CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the quarter ended June 30, 2022, as well as key clinical and corporate developments.

EV Biologics Corp, OTC Pink: YECO, today announced that it has launched Excyte, Inc., a wholly owned subsidiary, with $100 Million valuation.

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will feature Dr. Karen Knudsen, CEO of the American Cancer Society, at its inaugural Illumina Genomics Forum (IGF) on October 1.

Zynex, Inc today announced it has started enrollments in an ongoing apheresis clinical trial with its second-generation fluid monitoring system, the CM-1600.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the publication of a paper entitled, “Intravenous edaravone treatment in ALS and survival: an exploratory, retrospective, administrative claims analysis,” in eClinicalMedicine, part of The Lancet Discovery Science.

Tarsier Pharma, an advanced clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics for blinding ocular diseases, today announced development of TRS02, a slow-release formulation of TRS for intravitreal injection, to treat retinal diseases.

Awakn enters the U.S. addiction treatment and relapse prevention market

According to Nova one advisor’s latest research report on the global Recombinant DNA Technology market size was estimated at USD 690 billion in 2021 and is expected to surpass around USD 1079 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 5.09% during the forecast period 2022 to 2030.

The global plasmid DNA contract manufacturing market is expected to register significant growth in the forecast period.

Microplate readers (MR) are laboratory instruments used for the measurement of analytes and monitoring the progression of biochemical reactions carried out in microplates.